ICLR: ICON plc
Performance
ICLR +30.44%
Watchlist
Select an item
Summary
ICLR at a glance
ICLR returned +30.44% over the past year and -4.82% a year over five years. Its worst drop in that year was -60.54%, smaller than 12% of stocks on Redstone, and its Sharpe ratio of 0.72 beats 61% of stocks on Redstone. It pays no dividends.
Current Drawdown
-3.66%
Rolling Volatility
65.98%
Actions
Metrics
Risk Indicators
Alpha37.75%
Beta1.14x
Sharpe0.72
Sortino0.96
Omega1.17
Calmar0.50
Martin1.72
Profile
About ICLR
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies.
- Sector
- Health Care
- Market cap
- $15.6B
- Listed
- May 1998
- Employees
- 40,100
- Website
- iconplc.com
Comparisons